These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 22470132)

  • 1. SRT1720, a SIRT1 activator, promotes tumor cell migration, and lung metastasis of breast cancer in mice.
    Suzuki K; Hayashi R; Ichikawa T; Imanishi S; Yamada T; Inomata M; Miwa T; Matsui S; Usui I; Urakaze M; Matsuya Y; Ogawa H; Sakurai H; Saiki I; Tobe K
    Oncol Rep; 2012 Jun; 27(6):1726-32. PubMed ID: 22470132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sirtuin 1 activator SRT1720 suppresses inflammation in an ovalbumin-induced mouse model of asthma.
    Ichikawa T; Hayashi R; Suzuki K; Imanishi S; Kambara K; Okazawa S; Inomata M; Yamada T; Yamazaki Y; Koshimizu Y; Miwa T; Matsui S; Usui I; Urakaze M; Matsuya Y; Sasahara M; Tobe K
    Respirology; 2013 Feb; 18(2):332-9. PubMed ID: 23062010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SRT1720 induces lysosomal-dependent cell death of breast cancer cells.
    Lahusen TJ; Deng CX
    Mol Cancer Ther; 2015 Jan; 14(1):183-92. PubMed ID: 25411356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SIRT1 activation by SRT1720 attenuates bone cancer pain via preventing Drp1-mediated mitochondrial fission.
    Li MY; Ding JQ; Tang Q; Hao MM; Wang BH; Wu J; Yu LZ; Jiao M; Luo BH; Xie M; Zhu HL
    Biochim Biophys Acta Mol Basis Dis; 2019 Mar; 1865(3):587-598. PubMed ID: 30579931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Sirt1 activator, SRT1720, attenuates renal fibrosis by inhibiting CTGF and oxidative stress.
    Ren Y; Du C; Shi Y; Wei J; Wu H; Cui H
    Int J Mol Med; 2017 May; 39(5):1317-1324. PubMed ID: 28339034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The beneficial role of SIRT1 activator on chemo- and radiosensitization of breast cancer cells in response to IL-6.
    Masoumi H; Soltani A; Ghatrehsamani M
    Mol Biol Rep; 2020 Jan; 47(1):129-139. PubMed ID: 31781916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment with SRT1720, a SIRT1 activator, ameliorates fatty liver with reduced expression of lipogenic enzymes in MSG mice.
    Yamazaki Y; Usui I; Kanatani Y; Matsuya Y; Tsuneyama K; Fujisaka S; Bukhari A; Suzuki H; Senda S; Imanishi S; Hirata K; Ishiki M; Hayashi R; Urakaze M; Nemoto H; Kobayashi M; Tobe K
    Am J Physiol Endocrinol Metab; 2009 Nov; 297(5):E1179-86. PubMed ID: 19724016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Naringenin prevents TGF-β1 secretion from breast cancer and suppresses pulmonary metastasis by inhibiting PKC activation.
    Zhang F; Dong W; Zeng W; Zhang L; Zhang C; Qiu Y; Wang L; Yin X; Zhang C; Liang W
    Breast Cancer Res; 2016 Apr; 18(1):38. PubMed ID: 27036297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cucurbitacin E inhibits breast tumor metastasis by suppressing cell migration and invasion.
    Zhang T; Li J; Dong Y; Zhai D; Lai L; Dai F; Deng H; Chen Y; Liu M; Yi Z
    Breast Cancer Res Treat; 2012 Sep; 135(2):445-58. PubMed ID: 22842972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Licochalcone E present in licorice suppresses lung metastasis in the 4T1 mammary orthotopic cancer model.
    Kwon SJ; Park SY; Kwon GT; Lee KW; Kang YH; Choi MS; Yun JW; Jeon JH; Jun JG; Park JH
    Cancer Prev Res (Phila); 2013 Jun; 6(6):603-13. PubMed ID: 23625311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SIRT1 upregulation protects against liver injury induced by a HFD through inhibiting CD36 and the NF‑κB pathway in mouse kupffer cells.
    Niu B; He K; Li P; Gong J; Zhu X; Ye S; Ou Z; Ren G
    Mol Med Rep; 2018 Aug; 18(2):1609-1615. PubMed ID: 29845302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific Sirt1 Activator-mediated Improvement in Glucose Homeostasis Requires Sirt1-Independent Activation of AMPK.
    Park SJ; Ahmad F; Um JH; Brown AL; Xu X; Kang H; Ke H; Feng X; Ryall J; Philp A; Schenk S; Kim MK; Sartorelli V; Chung JH
    EBioMedicine; 2017 Apr; 18():128-138. PubMed ID: 28396013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SIRTUIN 1 ACTIVATOR SRT1720 PROTECTS AGAINST ORGAN INJURY INDUCED BY INTESTINAL ISCHEMIA-REPERFUSION.
    Hansen LW; Khader A; Yang WL; Prince JM; Nicastro JM; Coppa GF; Wang P
    Shock; 2016 Apr; 45(4):359-66. PubMed ID: 26263437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SIRT1 and AMPK mediate hypoxia-induced resistance of non-small cell lung cancers to cisplatin and doxorubicin.
    Shin DH; Choi YJ; Park JW
    Cancer Res; 2014 Jan; 74(1):298-308. PubMed ID: 24240701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Effects of SRT1720 Treatment on Endothelial Cells Derived from the Lung and Bone Marrow of Young and Aged, Male and Female Mice.
    Dadwal UC; Bhatti FUR; Awosanya OD; Staut CA; Nagaraj RU; Perugini AJ; Tewari NP; Valuch CR; Sun S; Mendenhall SK; Zhou D; Mostardo SL; Blosser RJ; Li J; Kacena MA
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SRT1720 induces SIRT1-independent cell death in adult T-cell leukemia/lymphoma.
    Kozako T; Kato N; Ohsugi T; Uchida YI; Yoshimitsu M; Ishitsuka K; Higaki Y; Sato H; Aikawa A; Honda SI
    FEBS J; 2022 Jun; 289(12):3477-3488. PubMed ID: 35029032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The SIRT1 activator SRT1720 reverses vascular endothelial dysfunction, excessive superoxide production, and inflammation with aging in mice.
    Gano LB; Donato AJ; Pasha HM; Hearon CM; Sindler AL; Seals DR
    Am J Physiol Heart Circ Physiol; 2014 Dec; 307(12):H1754-63. PubMed ID: 25326534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reverse chemomodulatory effects of the SIRT1 activators resveratrol and SRT1720 in Ewing's sarcoma cells: resveratrol suppresses and SRT1720 enhances etoposide- and vincristine-induced anticancer activity.
    Sonnemann J; Kahl M; Siranjeevi PM; Blumrich A; Blümel L; Becker S; Wittig S; Winkler R; Krämer OH; Beck JF
    J Cancer Res Clin Oncol; 2016 Jan; 142(1):17-26. PubMed ID: 26055805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Sirt1 activator SRT1720 attenuates angiotensin II-induced atherosclerosis in apoE⁻/⁻ mice through inhibiting vascular inflammatory response.
    Chen YX; Zhang M; Cai Y; Zhao Q; Dai W
    Biochem Biophys Res Commun; 2015 Oct; 465(4):732-8. PubMed ID: 26296466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SIRT1-independent mechanisms of the putative sirtuin enzyme activators SRT1720 and SRT2183.
    Huber JL; McBurney MW; Distefano PS; McDonagh T
    Future Med Chem; 2010 Dec; 2(12):1751-9. PubMed ID: 21428798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.